Nov 15 2017

William Garvin, Shareholder in the firm's FDA & Biotechnology section, moderated the panel "Serialization and Enforcement" at the Food and Drug Law Institute's Drug Quality and Security Act Conference.

Panelists focused on product identifiers and verification, FDA's guidance delaying enforcement for one year, public meetings, pilot projects and suspect packaging reporting.

Panelists included:

  • Brent G. Eilefson, Vice President, Legal Affairs, Upsher-Smith Laboratories, LLC
  • Justine Freisleben, Senior Director, Industry Relations, Healthcare Distribution Alliance
  • Connie Jung, Acting Associate Director for Policy and Communications, Office of Drug Security, Integrity, and Recalls, CDER, FDA
  • David Mason, AD Serialization ESO/Supply Chain, Sandoz
  • Chris Smith, Director, Federal Public Policy, National Association of Chain Drug Stores